Clinical Trials Browser

Terminated × Endometrial Neoplasms × Bevacizumab × Clear all

NCT05523440 2025-03-28

Bevacizumab and/or Niraparib in Patients With Recurrent Endometrial and/or Ovarian Cancer With ARID1A Mutation

Phase 2 Terminated

Ovarian Neoplasms, Endometrial Neoplasms